Sarcopenia and Muscle Loss: What Happens With Aging and What Actually Helps

What Is Sarcopenia?

Sarcopenia is often described simply as age-related muscle loss. That description is understandable, but it is incomplete.

Researchers have spent years trying to define exactly which combination of muscle size, strength and physical function should qualify as sarcopenia. Several diagnostic frameworks remain in use, and there is not yet one universally adopted operational definition.

The European Working Group on Sarcopenia in Older People, known as EWGSOP2, places low muscle strength at the beginning of the clinical diagnosis. Low strength indicates probable sarcopenia. Low muscle quantity or quality confirms the diagnosis, while poor physical performance identifies more severe disease.

More recently, the Global Leadership Initiative in Sarcopenia brought together experts from 29 countries to develop a global conceptual definition. Their 2024 consensus identified reduced muscle mass, reduced muscle strength and reduced muscle-specific strength as components of sarcopenia. Impaired physical performance was viewed primarily as a consequence rather than part of the conceptual definition itself.

The terminology may continue to evolve, but the clinical message is already clear. Sarcopenia cannot be diagnosed by looking only at someone's weight or even by measuring lean mass alone.

Sarcopenia Symptoms and Early Signs

Muscle loss can develop slowly enough that people compensate without realizing how much function has changed.

Early clues may include increasing difficulty getting out of a low chair, climbing stairs, carrying groceries, opening jars or lifting objects that previously felt easy. Walking may become slower. Balance can deteriorate. Someone may begin using their arms to push out of a chair or avoid activities that require strength because those activities have become more difficult.

Falls, repeated near-falls and prolonged recovery after illness are more concerning signs.

Visible muscle loss is not required. A person can lose muscle while body weight remains stable if fat mass increases at the same time.

This is one reason sarcopenia may remain unnoticed until physical limitations are already apparent.

Why Do We Lose Muscle With Age?

Aging muscle becomes less responsive to some of the signals that normally stimulate muscle protein synthesis. This reduced anabolic responsiveness is one reason older adults often require more attention to both resistance exercise and adequate dietary protein.

Age itself is only part of the explanation.

Physical inactivity is a major contributor. Muscle adapts to the work it is asked to perform, and prolonged periods without meaningful resistance reduce the stimulus required to maintain strength and tissue.

Low calorie intake and inadequate protein can accelerate the problem, particularly in older adults whose appetite has declined. Acute illness, hospitalization and prolonged bed rest can produce much more rapid losses.

Insulin resistance, obesity, chronic inflammatory disease, kidney disease, cancer and other medical conditions can contribute as well. Some medications, neurological disease, pain and arthritis indirectly affect muscle by making movement and training more difficult.

Hormonal changes accompany aging in both women and men, but muscle loss should not automatically be attributed to low estrogen or testosterone. The relationship is more complicated, and hormone therapy is not a stand-alone treatment for sarcopenia.

Sarcopenic Obesity: When Muscle Loss Hides Behind Body Weight

Sarcopenia does not occur only in thin or visibly frail people.

A person can carry substantial body fat while having relatively little muscle for their body size. This combination is often called sarcopenic obesity.

It can be easy to miss because body weight and BMI may be high rather than low. Someone may therefore appear to have abundant body tissue while still having poor muscular reserve.

Visceral fat adds another dimension. Excess visceral adiposity is associated with insulin resistance and metabolic disease, while low muscle strength reduces physical reserve. When both are present, focusing exclusively on weight loss can miss an important part of the problem.

For longevity medicine, the goal is not simply to make the number on the scale smaller. It is to improve body composition while protecting muscle and physical function.

Learn more in Body Composition and Longevity Medicine.

How Is Sarcopenia Diagnosed?

There is no single blood test for sarcopenia.

EWGSOP2 recommends a practical sequence called Find-Assess-Confirm-Severity.

Screening can begin with clinical suspicion or a questionnaire such as SARC-F. Someone reporting weakness, difficulty walking, difficulty rising from a chair, repeated falls or declining physical ability deserves further assessment.

Strength can then be evaluated with tests such as grip strength or repeated chair stands. Low strength raises concern for probable sarcopenia.

Muscle quantity can be evaluated with techniques such as DEXA or bioelectrical impedance. Research and specialty settings may also use CT or MRI.

Physical performance is assessed separately. Gait speed, the Short Physical Performance Battery, the Timed Up and Go test and longer walking tests are among the measures used to determine how much sarcopenia is affecting function.

Age, sex, height, ethnicity and the diagnostic framework being used can affect the interpretation of these measurements, which is one reason a number from one test should not be treated as a diagnosis by itself.

What Can DEXA Tell Us About Sarcopenia?

DEXA is useful because it provides an objective estimate of lean soft tissue throughout the body and in individual regions. Appendicular lean mass, which refers to lean tissue in the arms and legs, is commonly used in sarcopenia assessment.

DEXA does not measure skeletal muscle directly.

Lean soft tissue includes water and other non-fat tissues, and changes in hydration or glycogen can influence measurements. This becomes particularly relevant during rapid weight loss.

DEXA also cannot tell whether someone is strong. Two people with similar appendicular lean mass can have very different strength and physical function.

The advantage of DEXA is that muscle-related information can be considered alongside total body fat, regional fat distribution, visceral fat and bone density. That broader view is often more clinically useful than evaluating lean tissue in isolation.

At HormoneSynergy®, DEXA may be paired with SECA body-composition analysis when serial assessment can help determine whether someone is losing primarily fat, losing lean tissue, or changing both.

See DEXA Body Composition, Bone Density, and Visceral Fat.

Sarcopenia, Weight Loss and GLP-1 Medications

Substantial weight loss deserves special attention because weight loss is rarely composed entirely of fat.

Some lean-tissue loss normally accompanies calorie restriction. With semaglutide, tirzepatide and other incretin-based medications, this issue has become more visible because the amount of weight being lost can be much larger than with traditional dieting.

This does not mean GLP-1 medications inherently cause sarcopenia. The evidence is more nuanced. Studies show that reductions in lean mass can occur during treatment, while the effects on actual skeletal muscle, muscle quality, strength and physical performance remain less completely characterized. A 2026 review focusing on older adults specifically noted that sarcopenia and sarcopenic obesity deserve attention during obesity pharmacotherapy because older patients begin with less physiological reserve.

The practical response is not to avoid effective obesity treatment when it is medically appropriate. It is to make muscle preservation part of the treatment plan.

That means adequate protein, progressive resistance training and objective follow-up when substantial weight loss is occurring, especially in older adults or anyone who already has low lean mass or poor strength.

Read GLP-1s, Muscle Preservation, and the Future of Weight Loss in Longevity Medicine.

What Actually Helps Sarcopenia?

There is no medication currently established as a replacement for exercise in treating sarcopenia.

The strongest evidence supports physical training, particularly resistance-based exercise. A 2025 meta-analysis of 28 studies involving more than 2,500 adults with sarcopenia found that exercise improved physical performance and muscle strength, with resistance-based programs producing the most consistent effects.

Another 2025 analysis of randomized trials found improvements in grip strength, gait speed, knee-extension strength, chair-stand performance and Timed Up and Go testing with resistance training, although the size of improvement varied and not every outcome reached thresholds considered clinically meaningful.

Exercise programming therefore needs to be progressive enough to challenge muscle while remaining appropriate for the individual's mobility, joints, cardiovascular health and starting level of function.

For someone who has been sedentary for years, an appropriate program may begin with basic movements and relatively light resistance. A fitter older adult may need considerably more loading to produce adaptation.

Read Strength Training and Longevity Medicine.

Protein and Sarcopenia

Resistance training creates the stimulus for muscle adaptation. Dietary protein supplies the amino acids needed to support repair and synthesis.

Many healthy older adults benefit from protein intake above the basic adult RDA. Expert groups commonly discuss approximately 1.0 to 1.2 grams per kilogram of body weight per day for healthy older adults, with amounts around 1.2 to 1.6 g/kg/day often considered when muscle-preservation demands are greater, including during resistance training or substantial weight loss.

These ranges are not appropriate for everyone. Kidney disease, acute illness, body size, calorie intake and other medical conditions can substantially change protein requirements.

A 2024 meta-analysis specifically examining older adults with sarcopenia found that protein supplementation combined with resistance exercise improved muscle mass and strength, although the number of trials was limited.

The emphasis should remain on adequate total intake and an overall nutritious dietary pattern rather than assuming that progressively increasing protein will continue to produce larger muscle gains.

For a detailed discussion, see Protein Intake for Longevity: Muscle, Metabolism, and Healthy Aging.

Where Does Creatine Fit?

Creatine is one of the better studied nutritional supplements for muscle and resistance training.

Its role in aging is particularly interesting because creatine helps replenish phosphocreatine used during short, high-intensity muscular work and may allow people to perform more effective resistance training over time.

A 2025 systematic review and meta-analysis of randomized trials in older adults found that creatine combined with resistance training produced modest additional improvements in lean tissue and lower-body strength compared with resistance training alone.

The important phrase is combined with resistance training. Creatine should not be presented as a substitute for using the muscle.

For appropriate adults, creatine monohydrate can be considered as part of a muscle-preservation strategy.* RetzlerRx® Creatine Monohydrate is one option available through HormoneSynergy®.*

Hormones, Menopause and Muscle Loss

Hormonal changes occur alongside changes in muscle, bone and body composition with aging, which has led to considerable interest in whether hormone therapy can prevent sarcopenia.

In women, the menopausal transition often coincides with increases in fat mass and changes in lean tissue. Estrogen has effects on skeletal muscle biology, but menopause and sarcopenia should not be treated as though they are the same process.

A 2025 systematic review examining menopausal hormone therapy and sarcopenia-related outcomes found no consistent evidence that hormone therapy reliably improves strength, physical performance or muscle quantity. Many of the available studies were older, used outdated formulations and did not use modern consensus definitions of sarcopenia.

Hormone therapy may have legitimate indications for menopausal symptoms and other clinical considerations, but preventing or treating sarcopenia should not be used as a stand-alone justification for therapy based on the current evidence.

In men, testosterone deficiency can affect muscle and body composition, and appropriately diagnosed hypogonadism deserves medical evaluation. Testosterone therapy likewise should not be treated as a replacement for resistance training, nutrition or evaluation of other causes of muscle loss.

Can Sarcopenia Be Reversed?

Sarcopenia does not have to be viewed as an irreversible slide toward frailty.

The 2024 GLIS consensus specifically described sarcopenia as a potentially reversible disease. How much improvement is possible depends on the person's age, severity of muscle loss, chronic disease, nutrition, mobility and ability to train.

Strength often responds to training even in older adults. Muscle quantity can improve as well, although changes in muscle size may be smaller and slower than changes in performance.

For someone already experiencing significant frailty, the objective may not be to restore the body composition of middle age. Improvements in chair-rise ability, walking speed, balance or the ability to carry groceries can still represent meaningful clinical gains.

This is another reason functional measurements belong alongside DEXA and body-composition data.

The Bottom Line

Sarcopenia is not simply the observation that people tend to lose muscle as they get older. It is a clinically important disorder involving muscle mass and strength that can eventually affect mobility, recovery, falls and independence.

It can also be missed. Body weight may remain normal or elevated while muscle is declining, particularly when fat mass is increasing at the same time. DEXA can help identify low or declining appendicular lean tissue, but diagnosis requires attention to strength and physical function as well.

Resistance training remains the most important intervention. Adequate protein supports the adaptation to training, while creatine may provide a modest additional benefit for some older adults. Medical conditions, inadequate calorie intake, sleep, metabolic disease and hormonal problems should be addressed when they are contributing to muscle loss.

Rapid weight loss deserves particular attention because a successful reduction in body fat should not come at the expense of unnecessary loss of physical reserve.

The goal is not to accumulate the greatest possible amount of muscle. It is to retain enough strength and muscle capacity to move well, recover from illness and remain independent as long as possible.

Frequently Asked Questions

What is sarcopenia?

Sarcopenia is a disorder of skeletal muscle involving reduced muscle mass and strength. Definitions vary somewhat between expert groups, but modern criteria recognize that muscle function is at least as important as simply measuring muscle quantity.

What are the first signs of sarcopenia?

Early signs can include weaker grip, increasing difficulty rising from a chair, slower walking, trouble climbing stairs, reduced ability to lift or carry objects, declining activity and repeated falls or near-falls.

At what age does sarcopenia begin?

There is no single age at which sarcopenia begins. Muscle characteristics can change gradually during adulthood, but the prevalence of clinically significant sarcopenia rises substantially with age. Illness, inactivity and undernutrition can also produce sarcopenia earlier in life.

Can sarcopenia be reversed?

Sarcopenia is considered potentially reversible. Resistance training, adequate nutrition and treatment of contributing medical problems can improve strength, function and sometimes muscle quantity. The degree of improvement depends on the individual and severity of disease.

How is sarcopenia diagnosed?

Assessment commonly includes muscle-strength testing such as grip strength or chair stands, evaluation of muscle quantity with DEXA or BIA, and physical-performance tests such as gait speed or Timed Up and Go. No single measurement is sufficient in every case.

Can a DEXA scan diagnose sarcopenia?

DEXA can provide useful information about appendicular lean mass and body composition, but it does not measure strength or skeletal muscle directly. DEXA is best interpreted alongside strength and physical-performance testing.

Can an overweight person have sarcopenia?

Yes. Sarcopenia can occur together with obesity. Someone may have substantial body fat while carrying relatively little muscle for their body size or having poor strength. This is commonly referred to as sarcopenic obesity.

Do GLP-1 medications cause sarcopenia?

GLP-1 medications can produce substantial weight loss, and some lean tissue is typically lost along with fat. Current evidence does not establish that GLP-1 medications directly cause sarcopenia in most patients. Muscle preservation deserves additional attention in older adults and anyone losing substantial weight.

What type of exercise is best for sarcopenia?

Resistance-based exercise has the strongest evidence for improving strength and physical function in sarcopenia. Programs should be progressive and individualized for the person's starting strength, mobility, joint health and medical condition.

How much protein should an older adult eat to prevent muscle loss?

Many expert groups suggest approximately 1.0 to 1.2 grams per kilogram per day for healthy older adults, with higher amounts sometimes appropriate during resistance training, weight loss or illness. Kidney disease and other medical conditions can change protein needs.

Does creatine help sarcopenia?

Evidence suggests creatine can produce modest additional improvements in lean tissue and strength when combined with resistance training in older adults. It should be considered an adjunct to training rather than a replacement for it.

Related HormoneSynergy® Reading

• Bone, Muscle, and Strength Longevity Medicine
• Muscle Matters. But Longevity Is Bigger Than Muscle.
• Protein Intake for Longevity
• Strength Training and Longevity Medicine
• Body Composition and Longevity Medicine
• DEXA Body Composition, Bone Density, and Visceral Fat
• GLP-1s, Muscle Preservation, and the Future of Weight Loss

Selected Research

• Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31.
• Kirk B, et al. The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024;53(3):afae052.
• Effectiveness of Different Types of Exercise-Based Interventions in Sarcopenia: A Systematic Review and Meta-Analysis. 2025.
• The Effectiveness of Protein Supplementation Combined With Resistance Exercise Programs Among Community-Dwelling Older Adults With Sarcopenia: A Systematic Review and Meta-Analysis. 2024.
• The Impact of Creatine Supplementation Associated With Resistance Training on Muscular Strength and Lean Tissue Mass in the Aged: A Systematic Review and Meta-Analysis. 2025.
• Simsek H, Ucar A. GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia and Sarcopenic Obesity. Curr Nutr Rep. 2026.
• Systematic Review on the Relationship Between Menopausal Hormone Replacement Therapy, Sarcopenia, and Sarcopenia-Related Parameters. 2025.

*Important Notice: This article is educational and is not a substitute for individualized medical, nutritional or exercise advice. Protein intake, creatine use and exercise should be individualized for kidney function, medical history, medications, physical limitations and other clinical considerations.